Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
about
Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 AssaysEvaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumMulticenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNADried-Plasma Transport Using a Novel Matrix and Collection System for Human Immunodeficiency Virus and Hepatitis C Virus Virologic TestingIntra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaroundAdvances in developing HIV-1 viral load assays for resource-limited settingsEvaluation of a real-time nucleic acid sequence-based amplification assay using molecular beacons for detection of human immunodeficiency virus type 1.HIV-1 viral load assays for resource-limited settings.Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.Reliability at the lower limits of HIV-1 RNA quantification in clinical samples: a comparison of RT-PCR versus bDNA assaysViral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected womenEvaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.Current practices in laboratory monitoring of HIV infection.Ten years of external quality assessment of human immunodeficiency virus type 1 RNA quantification.Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African AmericansViral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide.Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beaconsStochastic processes defining sensitivity and variability of internally calibrated quantitative NASBA-based viral load assaysPerformance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT
P2860
Q27469990-E2F212DA-C2CB-4368-B444-B1EFF1D270FAQ27472747-FD731349-799D-4902-A247-CE32AC163C78Q27480924-8DD1F848-7535-4550-A92B-811A5866EFA6Q27488389-90D630D1-6694-4EE7-BC73-B125B318B160Q28364015-816398DD-0BD7-4C82-B2D2-83B41ED49930Q28730901-BE360202-BD29-416A-83FC-BF45F09F1A29Q30473238-4B49401F-767D-4D5F-9D73-B2714C4EB22DQ33245947-963579C0-752F-431F-9862-43D491A3DAD4Q33259966-1D24FC8A-2F1C-4B86-A74E-FBD1BF498F2FQ33410098-3BC4BD96-1F04-447F-B729-8620DAB2E5EDQ33472688-88457206-5C3A-4777-8A13-DFEC4865AB69Q33509024-BAF4900D-2CCD-4E22-93F8-27945FFB5E57Q33769514-9DEE2E14-C97A-46E4-ADDC-5517A6C3A453Q35077997-973D5D21-0F0E-427D-A1BB-2BF765337D3CQ35156353-53B375C0-ED00-43DD-A242-1B7B82B44382Q35770853-EEBE815C-F85D-48A0-9220-2601FC1DF8E5Q36362970-143EDFE7-D4AF-4787-A8EC-B9320DFEAE92Q36884491-4A286321-745E-40F0-977C-2344FA763109Q37186736-8DD4D3E6-3BF7-4462-8B0D-B68D23BE1002Q37259699-1A158BDE-92EF-4CC0-B3A5-AD80BBBA37CBQ39535849-6B0C9780-9325-4837-A6E7-66E69F04D095Q39696599-09C9869A-DAD3-4194-8D2F-1B38B082F828Q41961412-67724F7C-ECB7-415D-9371-5CBF2E93D9ABQ42211051-3B859077-0804-4EF6-BFEA-5FE99124D9D0
P2860
Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@en
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@nl
type
label
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@en
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@nl
prefLabel
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@en
Multicenter comparison of Roch ...... cy virus type 1 RNA in plasma.
@nl
P2093
P2860
P1476
Multicenter comparison of Roch ...... ncy virus type 1 RNA in plasma
@en
P2093
P2860
P304
P407
P577
2000-11-01T00:00:00Z